» Articles » PMID: 32908928

Risk Factors of Portal Vein Thrombosis After Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2020 Sep 10
PMID 32908928
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: We retrospectively reviewed medical records from cirrhosis patients who underwent devascularization for the treatment of portal hypertension in our hospital between January 1, 2008, and December 20, 2014. Patients were followed up to investigate the PVT incidence at different times after surgery. Patients were divided into two groups (PVT, no PVT), and the risk factors for PVT after surgery were determined.

Results: Until October 16, 2015, the median follow-up time of the 124 patients enrolled into this study was 41.43 months (range, 5.47-95.30 months). 61 patients had perioperative PVT, and 21 (16.94%) patients had PVT diagnosed during the follow-up period. Those who had lower preoperative white blood cell counts, larger preoperative portal vein trunk diameter, and no gastric varices were more likely to have perioperative thrombosis. In those without perioperative PVT, a history of hypertension, higher grade of splenomegaly, and higher preoperative levels of creatinine were independent predictors of PVT occurrence during the follow-up period.

Conclusions: The risk factors for perioperative PVT in cirrhotic patients after devascularization were lower preoperative white blood cell count and larger portal vein trunk diameter, with no gastric varices. A history of hypertension, a larger spleen, and higher preoperative creatinine level are independent predictors of PVT during follow-up after surgery in patients without perioperative PVT.

Citing Articles

Development and validation of an integrated model for the diagnosis of liver cirrhosis with portal vein thrombosis combined with endoscopic characters and blood biochemistry data: a retrospective propensity score matching (PSM) cohort study.

Yang J, Zhang X, Chen J, Hou X, Shi M, Yin L Ann Med. 2025; 57(1):2457521.

PMID: 39881530 PMC: 11784028. DOI: 10.1080/07853890.2025.2457521.


Inpatient management of thrombosis and hemostasis in patients with cirrhosis.

Roark R, Thandassery R Clin Liver Dis (Hoboken). 2024; 23(1):e0186.

PMID: 38903874 PMC: 11186815. DOI: 10.1097/CLD.0000000000000186.


Diagnostic Prediction of portal vein thrombosis in chronic cirrhosis patients using data-driven precision medicine model.

Li Y, Gao J, Zheng X, Nie G, Qin J, Wang H Brief Bioinform. 2024; 25(1).

PMID: 38221905 PMC: 10788706. DOI: 10.1093/bib/bbad478.


Machine learning predicts portal vein thrombosis after splenectomy in patients with portal hypertension: Comparative analysis of three practical models.

Li J, Wu Q, Zhu R, Lv X, Wang W, Wang J World J Gastroenterol. 2022; 28(32):4681-4697.

PMID: 36157936 PMC: 9476873. DOI: 10.3748/wjg.v28.i32.4681.


A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.

Xing Y, Tian Z, Jiang Y, Guan G, Niu Q, Sun X Ann Med. 2022; 54(1):302-309.

PMID: 35060835 PMC: 8786242. DOI: 10.1080/07853890.2022.2028893.


References
1.
Chen H, Trilok G, Wang F, Qi X, Xiao J, Yang C . A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics & risk factors. Indian J Med Res. 2014; 139(2):260-6. PMC: 4001338. View

2.
Zheng X, Liu Q, Yao Y . Laparoscopic splenectomy and esophagogastric devascularization is a safe, effective, minimally invasive alternative for the treatment of portal hypertension with refractory variceal bleeding. Surg Innov. 2012; 20(1):32-9. DOI: 10.1177/1553350612441863. View

3.
Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N . Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol. 1997; 7(2):246-8. DOI: 10.1007/s003300050145. View

4.
Yang L, Yuan L, Dong R, Yin J, Wang Q, Li T . Two surgical procedures for esophagogastric variceal bleeding in patients with portal hypertension. World J Gastroenterol. 2014; 19(48):9418-24. PMC: 3882417. DOI: 10.3748/wjg.v19.i48.9418. View

5.
Du L, Wu W, Zhang Y, Sun Z, Hu H, Liu X . Effects of modified splenocaval shunt plus devascularization on esophagogastric variceal bleeding: a comparative study of this treatment and devascularization only in cirrhotic portal hypertension. J Hepatobiliary Pancreat Sci. 2010; 17(5):657-65. DOI: 10.1007/s00534-010-0262-8. View